Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 41, Iss. 1, pp. 63-70
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
Stamatis Karakonstantis, Maria Rousaki, Evangelos I. Kritsotakis
Antibiotics (2022) Vol. 11, Iss. 6, pp. 723-723
Open Access | Times Cited: 147
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
Pranita D. Tamma, Emily L. Heil, Julie Ann Justo, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 135
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview
Claire Amaris Hobson, Gautier Pierrat, Olivier Tenaillon, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 115
Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants
Laurent Poirel, Mustafa Sadek, Ayda Kusaksizoglu, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 4, pp. 677-680
Closed Access | Times Cited: 44
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 4, pp. 573-580
Open Access | Times Cited: 38
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
Keith S. Kaye, Thierry Naas, Jason M. Pogue, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 3, pp. 777-806
Open Access | Times Cited: 35
Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
Chuanhai Wang, Deqing Yang, Yifan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam
T. A. Alsenani, S. L. Viviani, Vijay Kumar, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 4
Open Access | Times Cited: 33
Evolution of β-lactamase-mediated cefiderocol resistance
Christopher Frøhlich, Vidar Sørum, Nobuhiko Tokuriki, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 9, pp. 2429-2436
Open Access | Times Cited: 33
In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019
Mark G. Wise, James A. Karlowsky, Meredith Hackel, et al.
Microbial Drug Resistance (2023) Vol. 29, Iss. 8, pp. 360-370
Open Access | Times Cited: 20
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 604-604
Open Access | Times Cited: 19
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain
Juan Antonio Castillo-Polo, Marta Hernández-García, María Isabel Morosini, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 5, pp. 1259-1264
Closed Access | Times Cited: 17
Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy
Matteo Boattini, Gabriele Bianco, Lorena Charrier, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 4, pp. 431-439
Closed Access | Times Cited: 16
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–2021): emergence of complex resistance phenotypes
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
Journal of Chemotherapy (2022) Vol. 34, Iss. 5, pp. 302-310
Closed Access | Times Cited: 22
Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it’s even arrived?
Chiara Russo, Alessio Mesini, Marcello Mariani, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 4, pp. 624-631
Open Access | Times Cited: 5
Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae
Yun Wu, Wei Yu, Xiaobing Chu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 5
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies
Stefano Amadesi, Alberto Amedeo, Matteo Rinaldi, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116372-116372
Closed Access | Times Cited: 4
Photodynamic inactivation of KPC-producing Klebsiella pneumoniae difficult-to-treat resistance (DTR) by a cationic porphyrin
António A. Freitas, Hânstter Hállison Alves Rezende, Guilherme Rocha Lino de Souza, et al.
Journal of Photochemistry and Photobiology B Biology (2025) Vol. 265, pp. 113133-113133
Closed Access
Newly developed antibiotics against multidrug-resistant and carbapenem-resistant Gram-negative bacteria: action and resistance mechanisms
Sena Nur Başaran, Lütfiye Öksüz
Archives of Microbiology (2025) Vol. 207, Iss. 5
Closed Access
Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures
Sara Comini, Gabriele Bianco, Matteo Boattini, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 10, pp. 2632-2641
Closed Access | Times Cited: 20
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate
André Birgy, Christina Nnabuife, Timothy Palzkill
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4
Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures
Gabriele Bianco, Matteo Boattini, Alessandro Bondi, et al.
Journal of Hospital Infection (2022) Vol. 122, pp. 217-219
Open Access | Times Cited: 16
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
Marta Hernández-García, María García-Castillo, Marta Nieto-Torres, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 2, pp. 279-296
Closed Access | Times Cited: 10
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations
Alessandra Oliva, Dania Al Ismail, G. Arcari, et al.
Journal of Global Antimicrobial Resistance (2023) Vol. 33, pp. 321-327
Open Access | Times Cited: 9
Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022)
Matteo Boattini, Gabriele Bianco, Paulo Bastos, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 1, pp. 155-166
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top